Zydus FDA nod, SBI €150M, BL Kashyap ₹615 Cr order lead corporate updates

• HCLTech expanded its digital transformation partnership with Aurobay Technologies for global growth, managing SAP, Siemens Teamcenter PLM, and integration services.
• Can Fin Homes approved a ₹7 interim dividend per share and re-appointed Suresh Srinivasan Iyer as MD CEO, pending RBI approval.
• State Bank of India will sign a €150-million line of credit with Germany’s KfW on December 16 to fund climate-friendly energy projects.
• BL Kashyap and Sons secured a ₹615.69 crore work order from Sattva CKC for structural and civil works at the Sattva Chennai Knowledge City project.
• Zydus Lifesciences' US subsidiary Sentynl Therapeutics' NDA for Menkes disease therapy CUTX-101 was accepted by the FDA, with a new PDUFA date of January 14, 2026.

Why It Matters: These updates signal future growth and strategic shifts for key companies.